NASDAQ
NeuroSense Therapeutics Ltd. - Warrant (NRSNW)
♥ 511 Thanks from members
NeuroSense Therapeutics Ltd. (NRSNW) faces severe distress, highlighted by going concern doubts, low cash reserves, and Nasdaq compliance deadlines.
No chart available for this instrument.